What We Do
Our services focus on endpoints and outcomes for clinical trials.
And that is all we do.
Clinical outcome assessments (COAs), including patient-reported outcome (PRO), clinician-reported outcome (ClinRO), observer-reported outcome (ObsRO) and performance outcome (PerfO) instrument development to support labeling and marketing claims or a publication strategy.
Psychometric testing of endpoints to ensure that they are valid, reliable and responsive and demonstrate statistical and clinically meaningful differences against placebo and active treatments.
Identify existing clinical outcome assessments (COAs) that could be suitable as is or modified for use in future clinical trials, as well as identify information to inform the development of a conceptual framework or conceptual model.
Start with the end in mind: Development of an endpoint strategy from phase I to phase IV to ensure product differentiation at the time of market launch.
Leverage clinical trials to talk to patients about their experience to inform the measurement strategy and endpoint selection of future clinical studies.
Utilize survey research as a cost-effective and time-efficient means to collect information from large or hard-to-reach samples.
eCOA EQUIVALENCY TESTING
If a paper version of a clinical outcome assessment is migrated to an electronic format, additional testing of the electronic version may be needed to confirm that respondents interpret and respond similarly across versions.
Design regulatory and commercial communication strategies to secure labeling claims and enhanced market access position.
In the News
Endpoint Outcomes is pleased to welcome a new research associate to our Boston office:Prior to joining Endpoint Outcomes, Ian spent a year with AmeriCorps as a Site Coordinator for Reading Partners in Baltimore, Maryland. Ian holds a Bachelor of Arts with...read more
A manuscript co-authored by Chris Evans and Brooke Witherspoon reports on the preferences for use and design of electronic patient-reported outcomes in COPD. The results were recently published: Dumais KM, Dias N, Khurana L, Gary ST, Witherspoon B, Evans CJ,...read more
Endpoint Outcomes is pleased to welcome a new research associate to our Long Beach office:Flora is responsible for collecting, coding and analyzing patient-level data for the development and validation of patient, clinician or observer reported outcomes....read more